Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talactoferrin for Nosocomial Infection in Preterm Infants
NCT00854633Phase 2Unknown
- Sponsor
- Agennix AG
- Start
- Jun 2009
- Primary completion
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lactoferrin in nosocomial infection, necrotizing enterocolitis (NEC), sponsored by Agennix AG. Status: unknown.
02
Drugs
lactoferrin
03
Conditions
nosocomial infectionnecrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT00854633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854633.